Year |
Citation |
Score |
2022 |
Trevejo-Nuñez G, Lin B, Fan L, Aggor FEY, Biswas PS, Chen K, Gaffen SL. Regnase-1 Deficiency Restrains Klebsiella pneumoniae Infection by Regulation of a Type I Interferon Response. Mbio. e0379221. PMID 35100872 DOI: 10.1128/mbio.03792-21 |
0.325 |
|
2019 |
Majumder S, Amatya N, Revu S, Jawale CV, Wu D, Rittenhouse N, Menk A, Kupul S, Du F, Raphael I, Bhattacharjee A, Siebenlist U, Hand TW, Delgoffe GM, Poholek AC, ... ... Biswas PS, et al. IL-17 metabolically reprograms activated fibroblastic reticular cells for proliferation and survival. Nature Immunology. PMID 30962593 DOI: 10.1038/S41590-019-0367-4 |
0.306 |
|
2018 |
Ramani K, Jawale CV, Verma AH, Coleman BM, Kolls JK, Biswas PS. Unexpected kidney-restricted role for IL-17 receptor signaling in defense against systemic Candida albicans infection. Jci Insight. 3. PMID 29720566 DOI: 10.1172/jci.insight.98241 |
0.319 |
|
2017 |
Verma AH, Richardson JP, Zhou C, Coleman BM, Moyes DL, Ho J, Huppler AR, Ramani K, McGeachy MJ, Mufazalov IA, Waisman A, Kane LP, Biswas PS, Hube B, Naglik JR, et al. Oral epithelial cells orchestrate innate type 17 responses to Candida albicans through the virulence factor candidalysin. Science Immunology. 2. PMID 29101209 DOI: 10.1126/Sciimmunol.Aam8834 |
0.355 |
|
2015 |
Ramani K, Biswas PS. Interleukin 17 signaling drives Type I Interferon induced proliferative crescentic glomerulonephritis in lupus-prone mice. Clinical Immunology (Orlando, Fla.). PMID 26556529 DOI: 10.1016/j.clim.2015.10.009 |
0.303 |
|
2015 |
Whibley N, Jaycox JR, Reid D, Garg AV, Taylor JA, Clancy CJ, Nguyen MH, Biswas PS, McGeachy MJ, Brown GD, Gaffen SL. Delinking CARD9 and IL-17: CARD9 Protects against Candida tropicalis Infection through a TNF-α-Dependent, IL-17-Independent Mechanism. Journal of Immunology (Baltimore, Md. : 1950). 195: 3781-92. PMID 26336150 DOI: 10.4049/Jimmunol.1500870 |
0.336 |
|
2014 |
Huppler AR, Conti HR, Hernández-Santos N, Darville T, Biswas PS, Gaffen SL. Role of neutrophils in IL-17-dependent immunity to mucosal candidiasis. Journal of Immunology (Baltimore, Md. : 1950). 192: 1745-52. PMID 24442441 DOI: 10.4049/Jimmunol.1302265 |
0.331 |
|
2012 |
Biswas PS, Gupta S, Stirzaker RA, Kumar V, Jessberger R, Lu TT, Bhagat G, Pernis AB. Dual regulation of IRF4 function in T and B cells is required for the coordination of T-B cell interactions and the prevention of autoimmunity. The Journal of Experimental Medicine. 209: 581-96. PMID 22370718 DOI: 10.1084/jem.20111195 |
0.301 |
|
2011 |
Biswas PS, Gupta S, Chang E, Bhagat G, Pernis AB. Aberrant ROCK activation promotes the development of type I diabetes in NOD mice. Cellular Immunology. 266: 111-5. PMID 21111405 DOI: 10.1016/j.cellimm.2010.10.009 |
0.302 |
|
2010 |
Biswas PS, Gupta S, Chang E, Song L, Stirzaker RA, Liao JK, Bhagat G, Pernis AB. Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. The Journal of Clinical Investigation. 120: 3280-95. PMID 20697158 DOI: 10.1172/JCI42856 |
0.305 |
|
2008 |
Chen Q, Yang W, Gupta S, Biswas P, Smith P, Bhagat G, Pernis AB. IRF-4-binding protein inhibits interleukin-17 and interleukin-21 production by controlling the activity of IRF-4 transcription factor. Immunity. 29: 899-911. PMID 19062315 DOI: 10.1016/j.immuni.2008.10.011 |
0.312 |
|
2007 |
Biswas PS, Pedicord V, Ploss A, Menet E, Leiner I, Pamer EG. Pathogen-specific CD8 T cell responses are directly inhibited by IL-10. Journal of Immunology (Baltimore, Md. : 1950). 179: 4520-8. PMID 17878348 DOI: 10.4049/Jimmunol.179.7.4520 |
0.374 |
|
2007 |
Banerjee K, Biswas PS, Rouse BT. Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. 27: 65-75. PMID 17266445 DOI: 10.1089/Jir.2007.0077 |
0.725 |
|
2006 |
Biswas PS, Banerjee K, Kinchington PR, Rouse BT. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Experimental Eye Research. 82: 46-54. PMID 16009363 DOI: 10.1016/J.Exer.2005.05.001 |
0.732 |
|
2005 |
Polcicova K, Biswas PS, Banerjee K, Wisner TW, Rouse BT, Johnson DC. Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proceedings of the National Academy of Sciences of the United States of America. 102: 11462-7. PMID 16055558 DOI: 10.1073/pnas.0503230102 |
0.677 |
|
2005 |
Biswas PS, Banerjee K, Kim B, Kinchington PR, Rouse BT. Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. Journal of Virology. 79: 10589-600. PMID 16051851 DOI: 10.1128/Jvi.79.16.10589-10600.2005 |
0.715 |
|
2005 |
Biswas PS, Rouse BT. Early events in HSV keratitis--setting the stage for a blinding disease. Microbes and Infection / Institut Pasteur. 7: 799-810. PMID 15857807 DOI: 10.1016/J.Micinf.2005.03.003 |
0.595 |
|
2005 |
Biswas PS, Banerjee K, Kim B, Smith J, Rouse BT. A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Experimental Eye Research. 80: 73-81. PMID 15652528 DOI: 10.1016/J.Exer.2004.08.014 |
0.714 |
|
2005 |
Banerjee K, Biswas PS, Rouse BT. Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. Journal of Leukocyte Biology. 77: 24-32. PMID 15496448 DOI: 10.1189/Jlb.0904486 |
0.716 |
|
2004 |
Banerjee K, Biswas PS, Kumaraguru U, Schoenberger SP, Rouse BT. Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. Journal of Immunology (Baltimore, Md. : 1950). 173: 7575-83. PMID 15585885 DOI: 10.4049/Jimmunol.173.12.7575 |
0.724 |
|
2004 |
Kim B, Tang Q, Biswas PS, Xu J, Schiffelers RM, Xie FY, Ansari AM, Scaria PV, Woodle MC, Lu P, Rouse BT. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. The American Journal of Pathology. 165: 2177-85. PMID 15579459 DOI: 10.1016/S0002-9440(10)63267-1 |
0.565 |
|
2004 |
Biswas PS, Banerjee K, Zheng M, Rouse BT. Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. Journal of Leukocyte Biology. 76: 868-75. PMID 15258192 DOI: 10.1189/Jlb.0504280 |
0.703 |
|
2004 |
Deshpande S, Banerjee K, Biswas PS, Rouse BT. Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Reviews in Molecular Medicine. 6: 1-14. PMID 15061872 DOI: 10.1017/S1462399404007604 |
0.706 |
|
2004 |
Biswas PS, Banerjee K, Kim B, Rouse BT. Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. Journal of Immunology (Baltimore, Md. : 1950). 172: 3736-44. PMID 15004178 DOI: 10.4049/Jimmunol.172.6.3736 |
0.705 |
|
2004 |
Kumaraguru U, Suvas S, Biswas PS, Azkur AK, Rouse BT. Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo. Journal of Immunology (Baltimore, Md. : 1950). 172: 3719-24. PMID 15004176 DOI: 10.4049/Jimmunol.172.6.3719 |
0.511 |
|
2004 |
Banerjee K, Biswas PS, Kim B, Lee S, Rouse BT. CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. Journal of Immunology (Baltimore, Md. : 1950). 172: 1237-45. PMID 14707102 DOI: 10.4049/Jimmunol.172.2.1237 |
0.727 |
|
Show low-probability matches. |